Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Both 0.01% and 0.03% bimatoprost safely improve eyebrow fullness, with a patient preference for the 0.03% concentration.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

New treatments for skin diseases in 1979 showed promising results with fewer side effects.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Latanoprost's effectiveness for hair growth is not confirmed but shows promise, needing more research.

Tofacitinib treatment is used for teenagers with alopecia areata.

Bimatoprost solution 0.03% is effective for treating sparse eyelashes.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Clascoterone and minocycline are effective acne treatments with quick results and fewer side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Clascoterone may be a promising treatment for hair loss.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Calcipotriol does not improve the effectiveness of squaric acid dibutylester in treating alopecia areata.

A hair growth ointment improved hair length in a family with a genetic hair growth condition.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Misusing topical corticosteroids can cause skin darkening and other side effects.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.